These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Newborn babies will be tested for four more disorders, committee decides. Hawkes N BMJ; 2014 May; 348():g3267. PubMed ID: 25134132 [No Abstract] [Full Text] [Related]
24. [Newborn Screening Program in the Community of Madrid: evaluation of positive cases.]. Cambra Conejero A; Martínez Figueras L; Ortiz Temprado A; Blanco Soto P; Martín Rivada Á; Palomino Pérez L; Cañedo Villarroya E; Pedrón Giner C; Quijada Fraile P; Martín-Hernández E; García Silva MT; Chumillas Calzada S; Bellusci M; Belanger-Quintana A; Stanescu S; Martínez-Pardo Casanova M; Moráis López A; Bergua Martínez A; Ruiz-Salas P; Pérez González B; Ugarte M; Ruano MLF Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372917 [TBL] [Abstract][Full Text] [Related]
25. [Neonatal screening for metabolic diseases: need for efficacy studies]. Williams M Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1653-6. PubMed ID: 18714517 [TBL] [Abstract][Full Text] [Related]
26. Two inborn errors of metabolism in a newborn: glutaric aciduria type I combined with isobutyrylglycinuria. Popek M; Walter M; Fernando M; Lindner M; Schwab KO; Sass JO Clin Chim Acta; 2010 Dec; 411(23-24):2087-91. PubMed ID: 20836999 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of expanded newborn screening at Boston children's hospital: benefits and challenges in defining true disease. Landau YE; Waisbren SE; Chan LM; Levy HL J Inherit Metab Dis; 2017 Mar; 40(2):209-218. PubMed ID: 28054209 [TBL] [Abstract][Full Text] [Related]
28. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data. Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands. van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759 [TBL] [Abstract][Full Text] [Related]
31. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death. Manoukian AA; Ha CE; Seaver LH; Bhagavan NV Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588 [TBL] [Abstract][Full Text] [Related]
32. Increased parental anxiety and a benign clinical course: Infants identified with short-chain acyl-CoA dehydrogenase deficiency and isobutyryl-CoA dehydrogenase deficiency through newborn screening in Georgia. Sadat R; Hall PL; Wittenauer AL; Vengoechea ED; Park K; Hagar AF; Singh R; Moore RH; Gambello MJ Mol Genet Metab; 2020 Jan; 129(1):20-25. PubMed ID: 31813752 [TBL] [Abstract][Full Text] [Related]
33. Doctors' knowledge of the acute management of Inborn Errors of Metabolism. Hawkes CP; Walsh A; O'Sullivan S; Crushell E Acta Paediatr; 2011 Mar; 100(3):461-3. PubMed ID: 21133998 [No Abstract] [Full Text] [Related]
34. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912 [TBL] [Abstract][Full Text] [Related]
35. [Atypical course of a multiple acyl-CoA-dehydrogenase deficiency]. Rose M; Matern D; Millington DS; Lehnert W Klin Padiatr; 1999; 211(5):413-6. PubMed ID: 10572901 [TBL] [Abstract][Full Text] [Related]
36. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]. Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086 [TBL] [Abstract][Full Text] [Related]
37. Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054 [TBL] [Abstract][Full Text] [Related]
38. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK. Goddard P J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442 [TBL] [Abstract][Full Text] [Related]
39. Newborn screening--is it really that simple? Wiley V; Carpenter K; Bayliss U; Wilcken B Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():107-10. PubMed ID: 15906711 [TBL] [Abstract][Full Text] [Related]